Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- CheckyesterdayChange DetectedThe page has updated its date references, removing some past dates and adding new ones, indicating a shift in scheduling or availability. Additionally, the status has changed to 'Suspended', which may affect user engagement or service availability.SummaryDifference0.4%
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include new drug names related to metastatic colorectal cancer, such as Atezolizumab, Tiragolumab, and others, while significant details about the study's design and eligibility criteria have been removed.SummaryDifference20%
- Check30 days agoChange DetectedThe page has updated its revision number to v2.14.4 and changed its status to 'Active, not recruiting'. Additionally, the date has been updated to 2025-04-06.SummaryDifference0.7%
- Check38 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 10, 2025, and version 2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe study has increased its locations from 72 to 73 and has changed its status from 'Active, not recruiting' to 'Completed'.SummaryDifference0.8%
Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.